(Q45247422)

11 December 2017

title

Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer (English)

1 reference

11 December 2017

Seung Hyup Hyun

1

1 reference

11 December 2017

Hee Kyung Ahn

2

1 reference

11 December 2017

Hojoong Kim

3

1 reference

11 December 2017

Myung-Ju Ahn

4

1 reference

11 December 2017

Keunchil Park

5

1 reference

11 December 2017

Yong Chan Ahn

6

1 reference

11 December 2017

Jhingook Kim

7

1 reference

11 December 2017

Young Mog Shim

8

1 reference

11 December 2017

Joon Young Choi

9

1 reference

11 December 2017

publication date

16 August 2013

1 reference

11 December 2017

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

11 December 2017

volume

41

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

50-58

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-013-2530-8

11 December 2017

exact match

0 references

cites work

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Workin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Prognostic Significance of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Operable Primary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Time-dependent ROC curves for censored survival data and a diagnostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

A concordance correlation coefficient to evaluate reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Brain tumor imaging in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Partial-volume effect in PET tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2530-8

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study

21 January 2018

1 reference

12 December 2020

Non–Small Cell Lung Cancer

1 reference

12 December 2020

Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival

1 reference

12 December 2020

Comparison of diameter and perimeter methods for tumor volume calculation

1 reference

12 December 2020

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

1 reference

12 December 2020

The revised TNM staging system for lung cancer.

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications

1 reference

12 December 2020

Guidelines on the radical management of patients with lung cancer

1 reference

12 December 2020

SUV: standard uptake or silly useless value?

1 reference

12 December 2020

10.1007/S00259-013-2530-8

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1001305874

0 references

1 reference